about
Bone marrow trephine biopsy findings in B acute lymphoblastic leukaemia of early precursor (Pro-B) subtype.Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells.Abnormal villous morphology mimicking a hydatidiform mole associated with paternal trisomy of chromosomes 3,7,8 and unipaternal disomy of chromosome 11PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.Lineage-Specific Genes Are Prominent DNA Damage Hotspots during Leukemic Transformation of B Cell Precursors.EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors.hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia.Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies.Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma.Double minutes with MYC amplification in a patient with chronic myelomonocytic leukaemia transformed into acute myeloid leukaemia.Striking dyserythropoiesis in a myelodysplastic syndrome.Excellent outcome after repeated changes of tyrosine kinase inhibitor therapy for chronic myeloid leukaemia in complete cytogenetic response due to minor side effects.Observation of auer rods in crushed cells helps in the diagnosis of acute promyelocytic leukemiaUnexpected pancytopenia following treatment of acute lymphoblastic leukemiaBone marrow trephine biopsy findings in acute promyelocytic leukemiaBone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocationT cell lymphoblastic leukaemia/lymphoma associated with a microenvironment of thymic asteroid B cells in the bone marrowDetection of cryptic and variant IGH-MYC rearrangements in high-grade non-Hodgkin's lymphoma by fluorescence in situ hybridization: implications for cytogenetic testingCutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myelomaComplete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality
P50
Q33393819-CA49DCD1-A441-44DA-8108-CF4378427297Q34999190-5B5640F4-D9C0-4694-940F-397492C1563AQ36549544-43418E01-6741-41D0-AE1E-1CA45DDE07E2Q37200863-DA92A15A-5CFD-48F4-9DB7-4DC452D67069Q37654501-7C453C07-3E40-4F50-A162-3D749A6ACC44Q42882348-35E769F1-66C3-45E1-A9D2-0F88EB3AA0BEQ43072797-D2073EA7-46BE-4C53-AEA6-528E209BB554Q44270173-BF9D1C1E-26E0-4A07-8917-222E5E96BF50Q46027082-5CB2DBD4-EDEB-4558-9864-969DEC56AFB7Q46574493-2FF1BB27-B563-4220-901C-186BC2943684Q53033119-2D17D72F-A2F6-4884-B285-E5B4728BA489Q54397703-E8AB3835-5A8D-43BE-B351-DE9D75E10756Q63633902-C0AC0DB1-10E9-49A0-A8F5-AF86705C7CA4Q63633903-20D7CF34-7761-4069-B425-FE1560583736Q63633904-CB4C56C3-D753-475C-8EBD-2D03BDD9A435Q63633905-97841243-9270-43D1-B855-32F3929CCEE1Q63633906-7D723025-85A5-4C50-AF40-FED9E2BFE615Q63633907-42BB6DE1-1A37-4F4C-8E69-898918FB0465Q63633923-F479E384-6DEC-4114-BE6A-3CC91DDB341EQ93064399-15FEC5A4-81A7-4DF5-AB17-B8B1B16B5B73
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Philippa C May
@ast
Philippa C May
@en
Philippa C May
@es
Philippa C May
@nl
Philippa C May
@sl
type
label
Philippa C May
@ast
Philippa C May
@en
Philippa C May
@es
Philippa C May
@nl
Philippa C May
@sl
altLabel
Philippa C. May
@en
Philippa May
@en
prefLabel
Philippa C May
@ast
Philippa C May
@en
Philippa C May
@es
Philippa C May
@nl
Philippa C May
@sl
P106
P21
P31
P496
0000-0002-9033-4041